Technology and Methodology in Glaucoma Case Detection.
Summary
Even the most powerful handheld screening tool for glaucoma will not find cases cost-effectively because the disease prevalence is low.
Abstract
Even the most powerful handheld screening tool for glaucoma will not find cases cost-effectively because the disease prevalence is low. However, a tier 1 biomarker tool that enhances disease prevalence followed by the use of a screening tool could serve as a future glaucoma screening strategy.
More by Louis R Pasquale
View full profile →Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective.
Deep learning in ophthalmology: The technical and clinical considerations.
An Artificial Intelligence Approach to Detect Visual Field Progression in Glaucoma Based on Spatial Pattern Analysis.
Top Research in Diagnosis & Screening
Browse all →Efficacy of a Deep Learning System for Detecting Glaucomatous Optic Neuropathy Based on Color Fundus Photographs.
Dry eye disease and oxidative stress.
Central Corneal Thickness in the Ocular Hypertension Treatment Study (OHTS).
In the Knowledge Library
Discussion
Comments and discussion will appear here in a future update.